RTW Biotech Opportunities Ltd is a Guernsey-based company focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technolo ...
Dublin, Sept. 11, 2025 (GLOBE NEWSWIRE) -- The "Biotech, Pharmaceuticals & Genetics Industry Almanac 2026: Market Research, Statistics, Trends and Leading Companies" book from Plunkett Research Ltd ...
The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global regulations. Considering the advancements, fundamentally solid biotech stocks ...
Krystal Biotech, Inc. announced that it will present multiple research programs focused on lung, eye, and skin conditions at several scientific conferences in May and June 2025. The presentations ...
Our 35 Innovators Under 35 are the ones to watch—people whose research and technical work stands to shape the future of their ...
Stocktwits on MSN
Cathie Wood’s biotech bet Intellia secured an FDA priority review for rare genetic disorder therapy – retail sees upside in NTLA’s platform
The FDA set its PDUFA date for March 10, 2027. ・The agency also told Intellia it does not currently plan to hold an advisory committee meeting. ・ARK Invest purchased roughly $2.5 million worth of ...
Neuro-focused Encoded Therapeutics has bagged a $275 million series F round to support its Dravet syndrome asset and scale up ...
HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, announced its selection as the 2024 winner of the "Overall Genomics ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Krystal Biotech ( (KRYS)) just ...
This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Alex Ossola: Welcome to Tech News Briefing. It's Thursday, January 11th. I'm Alex ...
Biotech and medical device stocks saw notable moves Wednesday, led by Opus Genetics, which surged more than 27% following positive clinical data. Quantum BioPharma gained after receiving FDA clearance ...
Investor's Business Daily on MSN
Biotech stocks, with 'blowout' and 'bull case' results, rocket to record highs
Biotech stocks Roivant and Pharvaris hit records Tuesday on "blowout" and "bull case" results for lung and swelling disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results